BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elfil M, Kamel S, Kandil M, Koo BB, Schaefer SM. Implications of the Gut Microbiome in Parkinson's Disease. Mov Disord 2020;35:921-33. [DOI: 10.1002/mds.28004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Moustafa SA, Mohamed S, Dawood A, Azar J, Elmorsy E, Rizk NAM, Salama M. Gut brain axis: an insight into microbiota role in Parkinson's disease. Metab Brain Dis 2021. [PMID: 34370175 DOI: 10.1007/s11011-021-00808-2] [Reference Citation Analysis]
2 Ugrumov M. Development of early diagnosis of Parkinson's disease: Illusion or reality? CNS Neurosci Ther 2020. [PMID: 32597012 DOI: 10.1111/cns.13429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
3 Medel-Matus JS, Simpson CA, Ahdoot AI, Shin D, Sankar R, Jacobs JP, Mazarati AM. Modification of post-traumatic epilepsy by fecal microbiota transfer. Epilepsy Behav 2022;134:108860. [PMID: 35914438 DOI: 10.1016/j.yebeh.2022.108860] [Reference Citation Analysis]
4 Fleury V, Zekeridou A, Lazarevic V, Gaïa N, Giannopoulou C, Genton L, Cancela J, Girard M, Goldstein R, Bally JF, Mombelli A, Schrenzel J, Burkhard PR. Oral Dysbiosis and Inflammation in Parkinson's Disease. J Parkinsons Dis 2021;11:619-31. [PMID: 33646178 DOI: 10.3233/JPD-202459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis 2021;7:27. [PMID: 33692356 DOI: 10.1038/s41531-021-00156-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
6 Liu J, Zhang Y, Ye T, Yu Q, Yu J, Yuan S, Gao X, Wan X, Zhang R, Han W, Zhang Y. Effect of Coffee against MPTP-Induced Motor Deficits and Neurodegeneration in Mice Via Regulating Gut Microbiota. J Agric Food Chem 2022;70:184-95. [PMID: 35016506 DOI: 10.1021/acs.jafc.1c06998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhang C, Franklin CL, Ericsson AC. Consideration of Gut Microbiome in Murine Models of Diseases. Microorganisms 2021;9:1062. [PMID: 34068994 DOI: 10.3390/microorganisms9051062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Linard M, Ravier A, Mougué L, Grgurina I, Boutillier AL, Foubert-Samier A, Blanc F, Helmer C. Infectious Agents as Potential Drivers of α-Synucleinopathies. Mov Disord 2022. [PMID: 35040520 DOI: 10.1002/mds.28925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Avagliano C, Coretti L, Lama A, Pirozzi C, De Caro C, De Biase D, Turco L, Mollica MP, Paciello O, Calignano A, Meli R, Lembo F, Mattace Raso G. Dual-Hit Model of Parkinson's Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice-Neuroprotective and Anti-Inflammatory Effects of Butyrate. Int J Mol Sci 2022;23:6367. [PMID: 35742813 DOI: 10.3390/ijms23126367] [Reference Citation Analysis]
10 Sun Y, Cheng L, Zeng X, Zhang X, Liu Y, Wu Z, Weng P. The intervention of unique plant polysaccharides - Dietary fiber on depression from the gut-brain axis. Int J Biol Macromol 2021;170:336-42. [PMID: 33373637 DOI: 10.1016/j.ijbiomac.2020.12.164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Li X, Fan X, Yang H, Liu Y. Review of Metabolomics-Based Biomarker Research for Parkinson's Disease. Mol Neurobiol 2021. [PMID: 34826053 DOI: 10.1007/s12035-021-02657-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Peng H, Yu S, Zhang Y, Yin Y, Zhou J. Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration. Neurosci Bull . [DOI: 10.1007/s12264-022-00848-3] [Reference Citation Analysis]
13 Yang R, Gao G, Yang H. The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease. Front Aging Neurosci 2022;14:861035. [DOI: 10.3389/fnagi.2022.861035] [Reference Citation Analysis]
14 Kimber TE. Approach to the patient with early Parkinson disease: diagnosis and management. Intern Med J 2021;51:20-6. [DOI: 10.1111/imj.15148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 [DOI: 10.1101/2020.08.10.20171397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Chung KA, Pfeiffer RF. Gastrointestinal dysfunction in the synucleinopathies. Clin Auton Res 2021;31:77-99. [PMID: 33247399 DOI: 10.1007/s10286-020-00745-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chen H, Wang K, Scheperjans F, Killinger B. Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses. Neurobiol Dis 2021;163:105601. [PMID: 34954321 DOI: 10.1016/j.nbd.2021.105601] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Glinert A, Turjeman S, Elliott E, Koren O. Microbes, metabolites and (synaptic) malleability, oh my! The effect of the microbiome on synaptic plasticity. Biol Rev Camb Philos Soc 2021. [PMID: 34734461 DOI: 10.1111/brv.12812] [Reference Citation Analysis]
19 Chen Y, Zhou J, Wang L. Role and Mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol 2021;11:625913. [PMID: 33816335 DOI: 10.3389/fcimb.2021.625913] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
20 Elfil M, Bahbah EI, Attia MM, Eldokmak M, Koo BB. Impact of Obstructive Sleep Apnea on Cognitive and Motor Functions in Parkinson's Disease. Mov Disord 2021;36:570-80. [PMID: 33296545 DOI: 10.1002/mds.28412] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
21 Shen S, Zhang C, Xu YM, Shi CH. The Role of Pathogens and Anti-Infective Agents in Parkinson's Disease, from Etiology to Therapeutic Implications. J Parkinsons Dis 2021. [PMID: 34719435 DOI: 10.3233/JPD-212929] [Reference Citation Analysis]
22 Yan Z, Yang F, Cao J, Ding W, Yan S, Shi W, Wen S, Yao L. Alterations of gut microbiota and metabolome with Parkinson's disease. Microb Pathog 2021;160:105187. [PMID: 34530073 DOI: 10.1016/j.micpath.2021.105187] [Reference Citation Analysis]
23 Inczefi O, Bacsur P, Resál T, Keresztes C, Molnár T. The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease. Front Nutr 2022;9:718710. [PMID: 35548572 DOI: 10.3389/fnut.2022.718710] [Reference Citation Analysis]
24 Ghyselinck J, Verstrepen L, Moens F, Van Den Abbeele P, Bruggeman A, Said J, Smith B, Barker LA, Jordan C, Leta V, Chaudhuri KR, Basit AW, Gaisford S. Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease. Int J Pharm X 2021;3:100087. [PMID: 34977556 DOI: 10.1016/j.ijpx.2021.100087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
25 Dogra N, Mani RJ, Katare DP. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease. Cell Mol Neurobiol 2021. [PMID: 33649989 DOI: 10.1007/s10571-021-01066-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
26 Lubomski M, Xu X, Holmes AJ, Muller S, Yang JYH, Davis RL, Sue CM. Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease. Front Aging Neurosci 2022;14:881872. [DOI: 10.3389/fnagi.2022.881872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Miao Z, Bai J, Shen L, Singla RK. The Combination of Tradition and Future: Data-Driven Natural-Product-Based Treatments for Parkinson's Disease. Evid Based Complement Alternat Med 2021;2021:9990020. [PMID: 34335855 DOI: 10.1155/2021/9990020] [Reference Citation Analysis]
28 Wu Z, Zeng W, Zhang X, Yang J. Characterization of Acidic Tea Polysaccharides from Yellow Leaves of Wuyi Rock Tea and Their Hypoglycemic Activity via Intestinal Flora Regulation in Rats. Foods 2022;11:617. [PMID: 35206093 DOI: 10.3390/foods11040617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Harsanyiova J, Buday T, Kralova Trancikova A. Parkinson's Disease and the Gut: Future Perspectives for Early Diagnosis. Front Neurosci 2020;14:626. [PMID: 32625058 DOI: 10.3389/fnins.2020.00626] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
30 Pirazzini C, Azevedo T, Baldelli L, Bartoletti-Stella A, Calandra-Buonaura G, Dal Molin A, Dimitri GM, Doykov I, Gómez-Garre P, Hägg S, Hällqvist J, Halsband C, Heywood W, Jesús S, Jylhävä J, Kwiatkowska KM, Labrador-Espinosa MA, Licari C, Maturo MG, Mengozzi G, Meoni G, Milazzo M, Periñán-Tocino MT, Ravaioli F, Sala C, Sambati L, Schade S, Schreglmann S, Spasov S, Tenori L, Williams D, Xumerle L, Zago E, Bhatia KP, Capellari S, Cortelli P, Garagnani P, Houlden H, Liò P, Luchinat C, Delledonne M, Mills K, Mir P, Mollenhauer B, Nardini C, Pedersen NL, Provini F, Strom S, Trenkwalder C, Turano P, Bacalini MG, Franceschi C; PROPAG-AGEING Consortium. A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project. Mech Ageing Dev 2021;194:111426. [PMID: 33385396 DOI: 10.1016/j.mad.2020.111426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tarakad A, Jankovic J. Recent advances in understanding and treatment of Parkinson's disease. Fac Rev 2020;9:6. [PMID: 33659938 DOI: 10.12703/b/9-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Shadrina M, Slominsky P. Modeling Parkinson's Disease: Not Only Rodents? Front Aging Neurosci 2021;13:695718. [PMID: 34421573 DOI: 10.3389/fnagi.2021.695718] [Reference Citation Analysis]
33 Baert F, Matthys C, Maselyne J, Van Poucke C, Van Coillie E, Bergmans B, Vlaemynck G. Parkinson's disease patients' short chain fatty acids production capacity after in vitro fecal fiber fermentation. NPJ Parkinsons Dis 2021;7:72. [PMID: 34389734 DOI: 10.1038/s41531-021-00215-5] [Reference Citation Analysis]
34 Sharma M, Arora I, Stoll ML, Li Y, Morrow CD, Barnes S, Berryhill TF, Li S, Tollefsbol TO. Nutritional combinatorial impact on the gut microbiota and plasma short-chain fatty acids levels in the prevention of mammary cancer in Her2/neu estrogen receptor-negative transgenic mice. PLoS One 2020;15:e0234893. [PMID: 33382695 DOI: 10.1371/journal.pone.0234893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Schut GJ, Thorgersen MP, Poole FL 2nd, Haja DK, Putumbaka S, Adams MWW. Tungsten enzymes play a role in detoxifying food and antimicrobial aldehydes in the human gut microbiome. Proc Natl Acad Sci U S A 2021;118:e2109008118. [PMID: 34686601 DOI: 10.1073/pnas.2109008118] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhang L, Li S, Tai Z, Yu C, Xu Z. Gut Microbes Regulate Innate Immunity and Epilepsy. Front Neurosci 2022;16:870197. [PMID: 35720723 DOI: 10.3389/fnins.2022.870197] [Reference Citation Analysis]
37 Reed X, Schumacher-Schuh A, Hu J, Bandres-Ciga S. Advancing Personalized Medicine in Common Forms of Parkinson's Disease through Genetics: Current Therapeutics and the Future of Individualized Management. J Pers Med 2021;11:169. [PMID: 33804504 DOI: 10.3390/jpm11030169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Mol Med Rep 2021;24:734. [PMID: 34414447 DOI: 10.3892/mmr.2021.12374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Leggio L, Paternò G, Vivarelli S, L'Episcopo F, Tirolo C, Raciti G, Pappalardo F, Giachino C, Caniglia S, Serapide MF, Marchetti B, Iraci N. Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease. Biomolecules 2020;10:E1327. [PMID: 32948090 DOI: 10.3390/biom10091327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Lu CS, Chang HC, Weng YH, Chen CC, Kuo YS, Tsai YC. The Add-On Effect of Lactobacillus plantarum PS128 in Patients With Parkinson's Disease: A Pilot Study. Front Nutr 2021;8:650053. [PMID: 34277679 DOI: 10.3389/fnut.2021.650053] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Sun X, Xue L, Wang Z, Xie A. Update to the Treatment of Parkinson's Disease Based on the Gut-Brain Axis Mechanism. Front Neurosci 2022;16:878239. [PMID: 35873830 DOI: 10.3389/fnins.2022.878239] [Reference Citation Analysis]
42 Lauretani F, Longobucco Y, Maggio M. Gut microbiota and motoric-cognitive frailty in hospitalized older persons. Curr Opin Clin Nutr Metab Care 2021;24:209-15. [PMID: 33587364 DOI: 10.1097/MCO.0000000000000739] [Reference Citation Analysis]
43 Vijayakumar D, Jankovic J. Slowing Parkinson's Disease Progression with Vaccination and Other Immunotherapies. CNS Drugs 2022. [PMID: 35212935 DOI: 10.1007/s40263-022-00903-7] [Reference Citation Analysis]
44 Jellen LC, Lewis MM, Du G, Wang X, Galvis MLE, Krzyzanowski S, Capan CD, Snyder AM, Connor JR, Kong L, Mailman RB, Brundin P, Brundin L, Huang X. Low plasma serotonin linked to higher nigral iron in Parkinson's disease. Sci Rep 2021;11:24384. [PMID: 34934078 DOI: 10.1038/s41598-021-03700-2] [Reference Citation Analysis]